Urine Sediment Testing Market Report 2026

The urine sediment testing market size has grown strongly in recent years. It will grow from $2.03 trillion in 2025 to $2.2 trillion in 2026 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to increasing prevalence of urinary tract disorders, expansion of clinical diagnostic laboratories, rising demand for routine urinalysis, growth in hospital diagnostic capabilities, adoption of semi-automated testing systems.

The urine sediment testing market size is expected to see strong growth in the next few years. It will grow to $3.04 trillion in 2030 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to increasing integration of ai-based diagnostics, rising investments in laboratory automation, growing demand for rapid diagnostic turnaround, expansion of diagnostic testing in outpatient settings, increasing focus on precision diagnostics. Major trends in the forecast period include increasing adoption of fully automated urine sediment analyzers, growing use of AI-assisted image analysis, rising demand for high-throughput diagnostic systems, expansion of laboratory automation solutions, enhanced focus on diagnostic accuracy.

The growing elderly population is expected to drive the expansion of the urine sedimentation testing market. The senior population includes individuals aged 60 and above. Elderly individuals benefit from urine sediment testing as it helps detect kidney disorders and provides information on contributing factors, prognosis, pathogenic organisms, and antibiotic susceptibility. For example, in October 2024, the World Health Organization, a Switzerland-based health agency, reported that by 2030, one in six people worldwide will be aged 60 or older, with this number projected to reach 2.1 billion by 2050. Consequently, the increasing elderly population is fueling growth in the urine sedimentation testing market.

The rising prevalence of chronic kidney disease is also expected to propel the growth of the urine sediment testing market. Chronic kidney disease is characterized by the kidneys’ gradual loss of function, reducing their ability to filter blood effectively. Urine sediment testing is a simple, non-invasive procedure that provides valuable insights into kidney health and can be used for diagnosing and monitoring chronic kidney disease (CKD). For instance, in June 2023, Kidney Research UK, a UK-based non-profit organization, reported that approximately 7.2 million people in the UK are living with chronic kidney disease, accounting for over 10% of the population. Of these, 3.25 million are in advanced stages, while 3.9 million are in early stages. By 2033, the number of individuals affected by chronic kidney disease is expected to reach 7.61 million. Therefore, the increasing prevalence of chronic kidney disease is driving growth in the urine sediment testing market.

Key players in the urine sediment testing market are focusing on developing automated urinalysis systems to strengthen their market position. A urinalysis solution is used to test urine for various substances, including leukocytes (white blood cells), nitrites, protein, and glucose. For example, in October 2023, US-based Beckman Coulter Inc., a manufacturer of advanced biomedical testing solutions, launched the DxU Iris Workcell. This fully automated urinalysis system streamlines workflow and reduces manual reviews to just 4%. The DxU Iris Workcell employs proprietary Digital Flow Morphology technology combined with Auto-Particle Recognition (APR) software to isolate, identify, and characterize urine particles on-screen, effectively minimizing manual microscopy. The system is also designed for ease of use and maintenance, featuring a user-friendly interface that requires minimal training to operate.

Major companies operating in the urine sediment testing market are Abbott Laboratories, Siemens AG, F Hoffmann-La Roche Ltd, Sysmex Corporation, Beckman Coulter Inc, ARKRAY Inc, Mindray Medical International Limited, URIT Medical Electronic Co Ltd, Analyticon Biotechnologies AG, DIRUI Industrial Co Ltd, HUMAN Gesellschaft für Biochemica und Diagnostica GmbH, Menarini Diagnostics, Shenzhen Mindray Bio-Medical Electronics Co Ltd, URIT Medical Electronic Group Co Ltd.

North America was the largest region in the urine sediment testing market in 2025. The regions covered in the urine sediment testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the urine sediment testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the urine sediment testing market by increasing costs of imported optical components, imaging sensors, analyzers, and laboratory automation equipment. Diagnostic laboratories and hospitals in North America and Europe are most affected due to dependence on imported analyzers, while Asia-Pacific faces cost pressures on manufacturing and equipment exports. These tariffs are raising capital expenditure for laboratory upgrades and delaying equipment replacement cycles. However, they are also encouraging local manufacturing of diagnostic instruments, regional sourcing of components, and development of cost-efficient semi-automated testing systems.

The urine sediment testing market research report is one of a series of new reports that provides urine sediment testing market statistics, including urine sediment testing industry global market size, regional shares, competitors with a urine sediment testing market share, detailed urine sediment testing market segments, market trends and opportunities, and any further data you may need to thrive in the urine sediment testing industry. This urine sediment testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Urine sediment testing is a laboratory procedure used to examine the physical components of urine. It involves visual inspection of the urine, chemical analysis, and microscopic evaluation of the urinary sediment as part of a qualitative urinalysis. The results help guide prognosis and treatment planning.

The main types of urine sediment testing products are fully automatic urine sediment analyzers and semi-automatic urine sediment analyzers. A fully automatic urine sediment analyzer is capable of storing clinical data, dry chemical indices, microscopic examination results, and other extended analyses. These analyzers are used for detecting urinary tract infections, diabetes, kidney diseases, hypertension, and other conditions. End users include hospitals, diagnostic centers, clinics, ambulatory surgical centers, educational institutes, and other healthcare facilities.

The urine sediment testing market consists of sales of tubes, slides, urine sediment analyzer, and analytical kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.